Oxybutynin as an alternative treatment for hyperhidrosis
Open Access
- 1 March 2017
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 92 (2) , 217-220
Abstract
Hyperhidrosis is the excessive production of sweating, which can be primary and focal or secondary to various pathologies. The exact cause of primary focal hyperhidrosis is still unknown, although a genetic basis is recognized, and its prevalence varies from 1% to 2.8%. The most affected sites are the armpits, palms, soles and face. It causes much discomfort, affects the quality of life, and is estimated to be undervalued by health professionals. Many treatment options are proposed, both clinical and surgical. The aim of this review is to focus on the treatment of hyperhidrosis with oxybutynin, an anticholinergic drug originally used to control overactive bladder.Keywords
This publication has 51 references indexed in Scilit:
- Gravimetry in sweating assessment in primary hyperhidrosis and healthy individualsClinical Autonomic Research, 2013
- Hyperhidrosis: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum ToxinsToxins, 2013
- Oxybutynin reduces sweating in depressed patients treated with sertraline: a double-blind, placebo-controlled, clinical studyNeuropsychiatric Disease and Treatment, 2012
- Intérêt de l’oxybutynine à dose modérée dans l’hyperhidrose étendueAnnales de Dermatologie et de Vénéréologie, 2011
- An alternative to treat palmar hyperhidrosis: use of oxybutyninClinical Autonomic Research, 2011
- Oxybutynin for Antidepressant-Induced HyperhidrosisAmerican Journal of Psychiatry, 2011
- Primary hyperhidrosis controlled with oxybutynin after unsuccessful surgical treatmentClinical and Experimental Dermatology, 2009
- Prevalência de hiperidrose em uma amostra populacional de Blumenau - SC, BrasilAnais Brasileiros de Dermatologia, 2009
- Effect of oxybutynin on exercise‐induced sweating in healthy individualsJournal of Dermatological Treatment, 2008
- Exercise-induced Sweating in Healthy Subjects as a Model to Predict a Drug’s Sweat-reducing Properties in Hyperhydrosis: a Prospective, Placebo-controlled, Double-blind StudyActa Dermato-Venereologica, 2008